Similarly, dihydromyricetin has demonstrated the ability to normalize the differentiation of fibroblasts into MYFs and to reduce the proliferation, uncharacteristic migration, and respiratory functions of MYFs induced by TGF-β1 or those derived from patients with IPF [124]. Here, TGFB1 is linked to idiopathic pulmonary fibrosis.